Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients
Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions
Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have high response rate
Cellular immunotherapy for B cell cancers shows promise
City of Hope and ACCC: Current projects and future directions
Surveying the practicalities of geriatric care in USA
Polypharmacy and medication management in geriatric oncology
A dedicated, multidisciplinary support team for palliative care patients
Providing practical tips for completing geriatric assessments
The importance of SIOG's collaboration with ACCC
Updated recommendations for the management of elderly prostate cancer patients
JCOG: The Japan Clinical Oncology Group